KAI Pharmaceuticals, Inc. is a privately held, venture capital backed corporation. Our investors include:

	Aberdare Ventures
	Delphi Ventures
	Intersouth Partners
	InterWest Partners
	Investor Growth Capital, Inc.
	Kearny Venture Partners (Formerly Thomas Weisel Partners)
	Lumira Capital (Formerly MDS Capital)
	Skyline Ventures